Global Biotechnology - Market Research Report (2014-2029)
New York, United States
Last Updated: October 2024
L6724-GLRevenue
$558.8bn
Past 5-Year Growth
Profit
$XX.Xbn
Employees
1m
Businesses
12,487
Wages
$XX.Xbn
Global Biotechnology industry analysis
Explosive growth in biotechnology in recent years can't be understated. What's fueling this rapid growth varies, as biotech's applications range from healthcare and agriculture to energy. COVID-19 brought more attention to biotechnology, as biotech companies were central to vaccine development and reopening the economy. Biotech's potential to develop vaccines shifted the industry's trajectory, with investment reaching unprecedented levels globally and spurring more start-up activity than ever. Sky-high investment began settling in 2022 as higher interest rates moved risk-averse investors away from the industry. While investor uncertainty is alleviating in 2024, many biotechnology companies will still navigate a challenging funding environment. Globally, rising government investment toward biotechnology, specifically regarding R&D, expedited pathways and innovative therapies, helps offset this impact. In all, revenue has been expanding at a CAGR of 2.4% to an estimated $558.8 billion over the past five years, including expected growth of 2.4% in 2023.
Trends and Insights
- An uncertain funding environment creates challenges for biotechnology. While innovative areas haven’t felt the same funding pressures, the broader global industry has yet to see the industry return to 2021 highs as geopolitical tensions and economic headwinds weaken investor confidence.
- Biotechnology advances are transforming healthcare outcomes. Biotech’s potential to prevent, treat and eliminate disease makes healthcare products the most lucrative area on a global scale.
- The US is the global leader in biotechnology. Bustling biotech clusters across the US, a thriving start-up ecosystem and federal investment advance the country’s biotechnology goals.
- Biotechnology companies rely on funding to get products through the pipeline. Volatile financial markets and a more competitive funding environment puts companies that secure investment in a better position.
Industry Overview
Market size and recent performance (2014-2029)
Industry revenue has grown at a CAGR of 2.4 % over the past five years, to reach an estimated $558.8bn in 2024.
Trends and Insights
Biotechnology companies navigate a complex funding environment and pricing pressures
- Biotechnology companies' ability to bring new treatments to market relies heavily on external funding. This funding is crucial for supporting research and development (R&D), the backbone of innovation in the biotech industry. Without robust R&D efforts, companies can’t develop new treatments or secure the necessary patent protections that shield their investments and ensure future revenues.
- Additional trends and insights available with purchase
Source: 麻豆区
Industry outlook (2024-2029)
Market size is projected to grow over the next five years.
Trends and Insights
R&D funding will be crucial as ever
- Biotechnology companies must continue raising capital to fund research and development (R&D). But, a higher cost of capital for investors could shift investment activity moving forward.
Biggest companies in the Global Biotechnology
| Company | Market Share (%)
2024 | Revenue ($m)
2024 | Profit ($m)
2024 | Profit Margin (%)
2024 |
|---|---|---|---|---|
Johnson & Johnson | 37,116.8 | 8,449.2 | 22.8 | |
Merck & Co. Inc. | 34,428.3 | N/A | N/A | |
F. Hoffmann-La Roche AG | 31,683.2 | 11,259.3 | 35.5 |
To view the market share and analysis for all 7 top companies in this industry, view purchase options.
Products & Services Segmentation
Source: 麻豆区
Industry revenue is measured across several distinct product and services lines, including Human health technologies, Industrial technologies and Animal health technologies. Human health technologies is the largest segment of the Global Biotechnology.
Trends and Insights
Biotech is transformative to traditional healthcare delivery
- Biotechnology's applications for healthcare are rapidly evolving. The main areas of focus for biotech specializing in healthcare include diagnostics, therapeutics, genetics, cell transplants, personalized medicine, vaccines, biopharmaceuticals and tissue engineering.
- More insights available in the full report
Widen you competitive advantage with related industries
Competitors
- Global Basic Organic Chemicals Manufacturing
Complementors
- Global Fertilizers & Agricultural Chemicals Manufacturing
- Global Pharmaceuticals & Medicine Manufacturing
- Global Health Care Equipment Manufacturing
International industries
- Scientific Research & Development in the US
- Animal Health Biotechnology in the US
- DNA & DNA Forensic Laboratories in the US
- Contract Pharmaceutical Research Services in the US
- Clinical Trial Support Services in the US
Table of Contents
About this industry
Industry definition
Companies in the Global Biotechnology industry primarily use living organisms or molecular and cellular techniques to develop products used in agriculture, food, industrial and medicine production.
What's included in this industry?
DNA coding, mapping and sequencingProcessing biotechnologies Subcellular organism researchCell and tissue culture and engineering Protein sequencing, synthesis and engineering Producing biopharmaceuticalsCompanies
Johnson & JohnsonMerck & Co. Inc.F. Hoffmann-La Roche AGPurchase this report to view all 7 major companies in this industry.
Related Terms
GENETIC MODIFICATIONCLONINGGENE THERAPYVENTURE CAPITALPHARMACOGENOMICSPerformance
Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.
Analyst insights
An uncertain funding environment creates challenges for biotechnology. While innovative areas haven’t felt the same funding pressures, the broader global industry has yet to ...
In this chapter (4)
- Current Performance
- Outlook
- Volatility
- Life Cycle
Key metrics
- Annual Revenue, Recent Growth, Forecast, Revenue Volatility
- Number of Employees, Recent Growth, Forecast, Employees per Business, Revenue per Employee
- Number of Businesses, Recent Growth, Forecast, Employees per Business, Revenue per Business
- Total Profit, Profit Margin, Profit per Business
Charts
- Revenue, including historical (2014-2023) and forecast (2024-2029)
- Employees, including historical (2014-2023) and forecast (2024-2029)
- Businesses, including historical (2014-2023) and forecast (2024-2029)
- Profit, including historical (2014-2024)
- Industry Volatility vs. Revenue Growth
- Industry Life Cycle
Detailed analysis
- Trends in supply, demand and current events that are driving current industry performance
- Expected trends, economic factors and ongoing events that drive the industry's outlook
- Key success factors for businesses to overcome volatility
- How contribution to GDP, industry saturation, innovation, consolidation, and technology and systems influence the industry's life cycle phase.
Products and Markets
Learn about an industry's products and services, markets and trends in international trade.
Analyst insight
Biotechnology advances are transforming healthcare outcomes. Biotech’s potential to prevent, treat and eliminate disease makes healthcare products the most lucrative area on ...
In this chapter
- Products & Services
- Major Markets
- International Trade
Key metrics
- Largest market segment and value in 2024
- Product innovation level
- Total imports, level and trend
- Total exports, level and trend
- Trade Balance
Charts
- Products & services segmentation in 2024
- Major market segmentation in 2024
- International trade, including imports by country and exports by country
Detailed analysis
- Trends impacting the recent performance of the industry's various segments
- Innovations in the industry's product or service offering, specialization or delivery method
- Key factors that successful businesses consider in their offerings
- Buying segments and key trends influencing demand for industry products and services
- Recent trends in import and export volumes, country of origin or destination, and expected future trends
Geographic Breakdown
Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.
Analyst insights
The US is the global leader in biotechnology. Bustling biotech clusters across the US, a thriving start-up ecosystem and federal investment advance the country’s biotechnolog...
In this chapter (1)
- Business Locations
Charts
- Share of revenue, establishment, wages and employment in each region
- Share of population compared to establishments in each region in 2024
Tables
- Number and share of establishments in each region in 2024
- Number and share of revenue each region accounts for in 2024
- Number and share of wages each region accounts for in 2024
- Number and share of employees in each region in 2024
Detailed analysis
- Business Locations Charts
- Share of global output by region in 2024
- Share of population compared to output in each region in 2024
- Data tables
- Share of global output by region in 2024
- Detailed analysis
- Geographic spread of the industry across Global, and trends associated with changes in the business landscape
- Key success factors for businesses to use location to their advantage
Competitive Forces
Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.
Analyst insights
Biotechnology companies rely on funding to get products through the pipeline. Volatile financial markets and a more competitive funding environment puts companies that secure...
In this chapter (4)
- Concentration
- Barriers to Entry
- Substitutes
- Buyer & Supplier Analysis
Key metrics
- Industry concentration level
- Industry competition level and trend
- Barriers to entry level and trend
- Substitutes level and trend
- Buyer power level and trend
- Supplier power level and trend
Charts
- Market share concentration among the top 4 suppliers from 2019-2024
- Supply chain including upstream supplying industries and downstream buying industries, flow chart
Detailed analysis
- Factors impacting the industry鈥檚 level of concentration, such as business distribution, new entrants, or merger and acquisition activity.
- Key success factors for businesses to manage the competitive environment of the industry.
- Challenges that potential industry entrants face such as legal, start-up costs, differentiation, labor/capital intensity and capital expenses.
- Key success factors for potential entrants to overcome barriers to entry.
- Competitive threats from potential substitutes for the industry鈥檚 own products and services.
- Key success factors for how successful businesses can compete with substitutes.
- Advantages that buyers have to keep favorable purchasing conditions.
- Advantages that suppliers have to maintain favorable selling conditions.
- Key success factors for how businesses can navigate buyer and supplier power.
Companies
Learn about the performance of the top companies in the industry.
Analyst insights
Multinational pharmaceutical companies are leaders in biopharmaceutical production. Pharma producers like Novo Nordisk, Merck and Johnson and Johnson have extensive portfolio...
In this chapter
- Market Share Concentration
- Companies
- Company Spotlights
Charts
- Industry market share by company in 2020 through 2024
- Major companies in the industry, including market share, revenue, profit and profit margin in 2024
- Overview of Johnson & Johnson's performance by revenue, market share and profit margin from 2018 through 2024
- Overview of Merck & Co. Inc.'s performance by revenue, market share and profit margin from 2018 through 2024
- Overview of F. Hoffmann-La Roche AG's performance by revenue, market share and profit margin from 2018 through 2024
- Overview of revenue, market share and profit margin trend for 4 additional companies
Detailed analysis
- Description and key data for Johnson & Johnson, and factors influencing its performance in the industry
- Description and key data for Merck & Co. Inc., and factors influencing its performance in the industry
- Description and key data for F. Hoffmann-La Roche AG, and factors influencing its performance in the industry
- Description, key data and performance trends for 4 additional companies
External Environment
Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.聽 聽
Analyst insights
No comprehensive global regulatory framework oversees how biotechnology companies operate. A combination of national, regional and international regulations apply to various ...
In this chapter
- External Drivers
- Regulation & Policy
- Assistance
Key metrics
- Regulation & policy level and trend
- Assistance level and trend
Charts
- Regulation & Policy historical data and forecast (2014-2029)聽
- Assistance historical data and forecast (2014-2029)聽
Detailed analysis
- Demographic and macroeconomic factors influencing the industry, including Regulation & Policy and Assistance
- Major types of regulations, regulatory bodies, industry standards or specific regulations impacting requirements for industry operators
- Key governmental and non-governmental groups or policies that may provide some relief for industry operators.
Financial Benchmarks
View average costs for industry operators and compare financial data against an industry's financial benchmarks over time.聽
Analyst insights
Developing biotechnology products is a knowledge-intensive process. Biotechnology companies can’t move anything through the pipeline without teams of highly educated, special...
In this chapter
- Cost Structure
- Financial Ratios
- Key Ratios
Key metrics
- Profit margin, and how it compares to the sector-wide margin
- Average wages, and how it compares to the sector-wide average wage
- Largest cost component as a percentage of revenue
- Industry average ratios for days' receivables, industry coverage and debt-to-net-worth ratio
Charts
- Average industry operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
- Average sector operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
- Investment vs. share of economy
Data tables
- Cash Flow & Debt Service Ratios (2014-2029)
- Revenue per Employee (2014-2029)
- Revenue per Enterprise (2014-2029)
- Employees per Establishment (2014-2029)
- Employees per Enterprise (2014-2029)
- Average Wage (2014-2029)
- Wages/Revenue (2014-2029)
- Establishments per Enterprise (2014-2029)
- IVA/Revenue (2014-2029)
- Imports/Demand (2014-2029)
- Exports/Revenue (2014-2029)
Detailed analysis
- Trends in the cost component for industry operators and their impact on industry costs and profitability聽
Key Statistics
Industry Data
Data Tables
Including values and annual change:
- Revenue (2014-2029)
- IVA (2014-2029)
- Establishments (2014-2029)
- Enterprises (2014-2029)
- Employment (2014-2029)
- Exports (2014-2029)
- Imports (2014-2029)
- Wages (2014-2029)
Methodology
How are 麻豆区 reports created?
麻豆区 has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.
Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for 麻豆区 readers. Finally, each report is reviewed by one of 麻豆区鈥檚 editors, who provide quality assurance to ensure accuracy and readability.
麻豆区 relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.
What data sources do 麻豆区 analysts use?
Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.
Key data sources globally include:
- United Nations Comtrade
- Organization for Economic Cooperation & Development
- World Bank
Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.
These sources include:
- Industry and trade associations
- Industry federations or regulators
- Major industry players annual or quarterly filings
Finally, 麻豆区鈥檚 global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.
How does 麻豆区 forecast its data?
麻豆区鈥檚 analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.
麻豆区 prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.
Learn more about our methodology and data sourcing on the .
Frequently Asked Questions
Unlock comprehensive answers and precise data upon purchase. View purchase options.
What is the market size of the Global Biotechnology industry in Global in 2024?
The market size of the Global Biotechnology industry in Global is $558.8bn in 2024.
How many businesses are there in the Global Biotechnology industry in 2024?
There are 12,487 businesses in the Global Biotechnology industry in Global, which has grown at a CAGR of 6.3 % between 2019 and 2024.
Has the Global Biotechnology industry in Global grown or declined over the past 5 years?
The market size of the Global Biotechnology industry in Global has been growing at a CAGR of 2.4 % between 2019 and 2024.
What is the forecast growth of the Global Biotechnology industry in Global over the next 5 years?
Over the next five years, the Global Biotechnology industry in Global is expected to grow.
What are the biggest companies in the Global Biotechnology market in Global?
The biggest companies operating in the Global Biotechnology market in Global are Johnson & Johnson, Merck & Co. Inc. and F. Hoffmann-La Roche AG
What does the Global Biotechnology in Global include?
DNA coding, mapping and sequencing and Processing biotechnologies are part of the Global Biotechnology industry.
Which companies have the highest market share in the Global Biotechnology in Global?
The company holding the most market share in Global is Johnson & Johnson.
How competitive is the Global Biotechnology industry in Global?
The level of competition is very high and increasing in the Global Biotechnology industry in Global.
